Aspirin May Lower Cardiovascular Risks in Chronic Kidney Disease Population
Aspirin use among patients with chronic kidney disease was associated with reduced risk for major adverse cardiovascular events.
Aspirin use among patients with chronic kidney disease was associated with reduced risk for major adverse cardiovascular events.
Some in-hospital therapies and prophylactic treatments may confer no benefit or are potentially harmful and should be reconsidered
These recommendations only apply to individuals who do not have a history of CVD and are not already taking daily aspirin.
USPSTF recommends against hormone therapy for primary prevention of chronic conditions in postmenopausal persons
Salt substitute intervention shown to be cost-saving among individuals with prior stroke or uncontrolled high blood pressure living in rural China
Mrs D retained an attorney and filed suit against Dr H and the hospital, alleging medical negligence and failure to obtain informed consent.
The Cionic Neural Sleeve is the first product to combine movement analysis and augmentation into a wearable garment.
A review of regulatory and drug development status updates.
Recent use of non-vitamin K antagonist oral anticoagulant not linked to increased risk for intracranial hemorrhage with IV alteplase
Statin use recommended for people aged 40 to 75 years with CV risk factor(s) and higher 10-year risk for a CV event